{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:52:19Z","timestamp":1794016339608,"version":"4.8.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T00:00:00Z","timestamp":1677456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T00:00:00Z","timestamp":1677456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U20A20369"],"award-info":[{"award-number":["U20A20369"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81901687"],"award-info":[{"award-number":["81901687"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1604286"],"award-info":[{"award-number":["U1604286"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["JCYJ20190807154819245"],"award-info":[{"award-number":["JCYJ20190807154819245"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["KQTD20190929173853397"],"award-info":[{"award-number":["KQTD20190929173853397"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018627","name":"Science and Technology Support Plan for Youth Innovation of Colleges and Universities of Shandong Province of China","doi-asserted-by":"publisher","award":["2019ZT08Y464"],"award-info":[{"award-number":["2019ZT08Y464"]}],"id":[{"id":"10.13039\/501100018627","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Esophageal squamous cell carcinoma (ESCC) is a common gastrointestinal malignancy with poor patient prognosis. Current treatment for ESCC, including immunotherapy, is only beneficial for a small subset of patients. Better characterization of the tumor microenvironment (TME) and the development of novel therapeutic targets are urgently needed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In the present study, we hypothesized that integration of single-cell transcriptomic sequencing and large microarray sequencing of ESCC biopsies would reveal the key cell subtypes and therapeutic targets that determine the prognostic and tumorigenesis of ESCC. We characterized the gene expression profiles, gene sets enrichment, and the TME landscape of a microarray cohort including 84 ESCC tumors and their paired peritumor samples. We integrated single-cell transcriptomic sequencing and bulk microarray sequencing of ESCC to reveal key cell subtypes and druggable targets that determine the prognostic and tumorigenesis of ESCC. We then designed and screened a blocking peptide targeting Chemokine C\u2013C motif ligand 18 (CCL18) derived from tumor associated macrophages and validated its potency by MTT assay. The antitumor activity of CCL18 blocking peptide was validated in vivo by using 4-nitroquinoline-1-oxide (4-NQO) induced spontaneous ESCC mouse model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Comparative gene expression and cell\u2013cell interaction analyses revealed dysregulated chemokine and cytokine pathways during ESCC carcinogenesis. TME deconvolution and cell interaction analyses allow us to identify the chemokine CCL18 secreted by tumor associated macrophages could promote tumor cell proliferation via JAK2\/STAT3 signaling pathway and lead to poor prognosis of ESCC. The peptide Pep3 could inhibit the proliferation of EC-109 cells promoted by CCL18 and significantly restrain the tumor progression in 4-NQO-induced spontaneous ESCC mouse model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>For the first time, we discovered and validated that CCL18 blockade could significantly prevent ESCC progression. Our study revealed the comprehensive cell\u2013cell interaction network in the TME of ESCC and provided novel therapeutic targets and strategies to ESCC treatment.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13046-023-02612-5","type":"journal-article","created":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T06:02:28Z","timestamp":1677477748000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Integrative analysis of bulk and single-cell gene expression profiles to identify tumor-associated macrophage-derived CCL18 as a therapeutic target of esophageal squamous cell carcinoma"],"prefix":"10.1186","volume":"42","author":[{"given":"Xinghua","family":"Sui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuman","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyan","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoying","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjie","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfeng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,27]]},"reference":[{"key":"2612_CR1","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1053\/j.gastro.2017.08.023","volume":"154","author":"CC Abnet","year":"2018","unstructured":"Abnet CC, Arnold M, Wei W-Q. Epidemiology of esophageal squamous cell carcinoma. Gastroenterology. 2018;154:360\u201373.","journal-title":"Gastroenterology"},{"key":"2612_CR2","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1053\/j.gastro.2016.01.035","volume":"150","author":"G Sawada","year":"2016","unstructured":"Sawada G, Niida A, Uchi R, Hirata H, Shimamura T, Suzuki Y, Shiraishi Y, Chiba K, Imoto S, Takahashi Y, et al. Genomic landscape of esophageal squamous cell carcinoma in a Japanese population. Gastroenterology. 2016;150:1171\u201382.","journal-title":"Gastroenterology"},{"key":"2612_CR3","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/nyas.13144","volume":"1381","author":"Y Liu","year":"2016","unstructured":"Liu Y, Xiong Z, Beasley A, D\u2019Amico T, Chen XL. Personalized and targeted therapy of esophageal squamous cell carcinoma: an update. Ann NY Acad Sci. 2016;1381:66\u201373.","journal-title":"Ann NY Acad Sci"},{"key":"2612_CR4","doi-asserted-by":"crossref","unstructured":"Metges J, Fran\u00e7ois E, Shah M, Adenis A, Enzinger P, Kojima T, Muro K, Bennouna J, Hsu C, Moriwaki T, et al: O-012The phase 3 KEYNOTE-181 study: pembrolizumab versus chemotherapy as second-line therapy for advanced esophageal cancer. Ann Oncol 2019, 30.","DOI":"10.1093\/annonc\/mdz154.011"},{"key":"2612_CR5","first-page":"1","volume":"30","author":"W Chen","year":"2018","unstructured":"Chen W, Sun K, Zheng R, Zeng H, Zhang S, Xia C, Yang Z, Li H, Zou X, He J. Cancer incidence and mortality in China, 2014. China Oncol. 2018;30:1\u201312.","journal-title":"China Oncol"},{"key":"2612_CR6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nature13176","volume":"509","author":"Y Song","year":"2014","unstructured":"Song Y, Li L, Ou Y, Gao Z, Li E, Li X, Zhang W, Wang J, Xu L, Zhou Y, et al. Identification of genomic alterations in oesophageal squamous cell cancer. Nature. 2014;509:91\u20135.","journal-title":"Nature"},{"key":"2612_CR7","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/ng.3076","volume":"46","author":"Y-B Gao","year":"2014","unstructured":"Gao Y-B, Chen Z-L, Li J-G, Hu X-D, Shi X-J, Sun Z-M, Zhang F, Zhao Z-R, Li Z-T, Liu Z-Y, et al. Genetic landscape of esophageal squamous cell carcinoma. Nat Genet. 2014;46:1097\u2013102.","journal-title":"Nat Genet"},{"key":"2612_CR8","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1038\/s41467-019-09255-1","volume":"10","author":"T Yan","year":"2019","unstructured":"Yan T, Cui H, Zhou Y, Yang B, Kong P, Zhang Y, Liu Y, Wang B, Cheng Y, Li J, et al. Multi-region sequencing unveils novel actionable targets and spatial heterogeneity in esophageal squamous cell carcinoma. Nat Commun. 2019;10:1670.","journal-title":"Nat Commun"},{"key":"2612_CR9","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1126\/science.aau3879","volume":"362","author":"I Martincorena","year":"2018","unstructured":"Martincorena I, Fowler JC, Wabik A, Lawson ARJ, Abascal F, Hall MWJ, Cagan A, Murai K, Mahbubani K, Stratton MR, et al. Somatic mutant clones colonize the human esophagus with age. Science. 2018;362:911\u20137.","journal-title":"Science"},{"key":"2612_CR10","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1053\/j.gastro.2017.06.066","volume":"154","author":"D-C Lin","year":"2018","unstructured":"Lin D-C, Wang M-R, Koeffler HP. Genomic and epigenomic aberrations in esophageal squamous cell carcinoma and implications for patients. Gastroenterology. 2018;154:374\u201389.","journal-title":"Gastroenterology"},{"key":"2612_CR11","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1038\/ng.3683","volume":"48","author":"J-J Hao","year":"2016","unstructured":"Hao J-J, Lin D-C, Dinh HQ, Mayakonda A, Jiang Y-Y, Chang C, Jiang Y, Lu C-C, Shi Z-Z, Xu X, et al. Spatial intratumoral heterogeneity and temporal clonal evolution in esophageal squamous cell carcinoma. Nat Genet. 2016;48:1500\u20137.","journal-title":"Nat Genet"},{"key":"2612_CR12","doi-asserted-by":"publisher","first-page":"3528","DOI":"10.1158\/1078-0432.CCR-18-4085","volume":"25","author":"B Li","year":"2019","unstructured":"Li B, Cui Y, Nambiar DK, Sunwoo JB, Li R. The immune subtypes and landscape of squamous cell carcinoma. Clin Cancer Res. 2019;25:3528\u201337.","journal-title":"Clin Cancer Res"},{"key":"2612_CR13","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M, Coussens LM, Gabrilovich DI, Ostrand-Rosenberg S, Hedrick CC, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med. 2018;24:541\u201350.","journal-title":"Nat Med"},{"key":"2612_CR14","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1356147","volume":"6","author":"Y Li","year":"2017","unstructured":"Li Y, Lu Z, Che Y, Wang J, Sun S, Huang J, Mao S, Lei Y, Chen Z, He J. Immune signature profiling identified predictive and prognostic factors for esophageal squamous cell carcinoma. OncoImmunology. 2017;6: e1356147.","journal-title":"OncoImmunology"},{"key":"2612_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1479-5876-10-1","volume":"10","author":"J Galon","year":"2012","unstructured":"Galon J, Pag\u00e8s F, Marincola FM, Thurin M, Trinchieri G, Fox BA, Gajewski TF, Ascierto PA. The immune score as a new possible approach for the classification of cancer. J Transl Med. 2012;10:1.","journal-title":"J Transl Med"},{"key":"2612_CR16","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.ccr.2011.02.006","volume":"19","author":"J Chen","year":"2011","unstructured":"Chen J, Yao Y, Gong C, Yu F, Su S, Chen J, Liu B, Deng H, Wang F, Lin L, et al. CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3. Cancer Cell. 2011;19:541\u201355.","journal-title":"Cancer Cell"},{"key":"2612_CR17","doi-asserted-by":"publisher","first-page":"34758","DOI":"10.18632\/oncotarget.5325","volume":"6","author":"L Lin","year":"2015","unstructured":"Lin L, Chen YS, Yao YD, Chen JQ, Chen JN, Huang SY, Zeng YJ, Yao HR, Zeng SH, Fu YS, Song EW. CCL18 from tumor-associated macrophages promotes angiogenesis in breast cancer. Oncotarget. 2015;6:34758\u201373.","journal-title":"Oncotarget"},{"key":"2612_CR18","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1007\/s13277-015-4172-x","volume":"37","author":"Z Lin","year":"2016","unstructured":"Lin Z, Li W, Zhang H, Wu W, Peng Y, Zeng Y, Wan Y, Wang J, Ouyang N. CCL18\/PITPNM3 enhances migration, invasion, and EMT through the NF-kappaB signaling pathway in hepatocellular carcinoma. Tumour Biol. 2016;37:3461\u20138.","journal-title":"Tumour Biol"},{"key":"2612_CR19","first-page":"2941","volume":"35","author":"B Nabeki","year":"2015","unstructured":"Nabeki B, Ishigami S, Uchikado Y, Sasaki K, Kita Y, Okumura H, Arigami T, Kijima Y, Kurahara H, Maemura K, Natsugoe S. Interleukin-32 expression and Treg infiltration in esophageal squamous cell carcinoma. Anticancer Res. 2015;35:2941\u20137.","journal-title":"Anticancer Res"},{"key":"2612_CR20","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1177\/0300060513488504","volume":"41","author":"M Xia","year":"2013","unstructured":"Xia M, Zhao MQ, Wu K, Lin XY, Liu Y, Qin YJ. Investigations on the clinical significance of FOXP3 protein expression in cervical oesophageal cancer and the number of FOXP3+ tumour-infiltrating lymphocytes. J Int Med Res. 2013;41:1002\u20138.","journal-title":"J Int Med Res"},{"key":"2612_CR21","doi-asserted-by":"publisher","first-page":"5439","DOI":"10.1158\/0008-5472.CAN-07-6621","volume":"68","author":"P Serafini","year":"2008","unstructured":"Serafini P, Mgebroff S, Noonan K, Borrello I. Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells. Cancer Res. 2008;68:5439\u201349.","journal-title":"Cancer Res"},{"key":"2612_CR22","doi-asserted-by":"publisher","first-page":"689","DOI":"10.4049\/jimmunol.168.2.689","volume":"168","author":"A Mazzoni","year":"2002","unstructured":"Mazzoni A, Bronte V, Visintin A, Spitzer JH, Apolloni E, Serafini P, Zanovello P, Segal DM. Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism. J Immunol. 2002;168:689\u201395.","journal-title":"J Immunol"},{"key":"2612_CR23","doi-asserted-by":"publisher","first-page":"4336","DOI":"10.1182\/blood-2006-09-046201","volume":"109","author":"C Liu","year":"2007","unstructured":"Liu C, Yu S, Kappes J, Wang J, Grizzle WE, Zinn KR, Zhang HG. Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host. Blood. 2007;109:4336\u201342.","journal-title":"Blood"},{"key":"2612_CR24","doi-asserted-by":"publisher","first-page":"5291","DOI":"10.1038\/s41467-021-25539-x","volume":"12","author":"X Zhang","year":"2021","unstructured":"Zhang X, Peng L, Luo Y, Zhang S, Pu Y, Chen Y, Guo W, Yao J, Shao M, Fan W, et al. Dissecting esophageal squamous-cell carcinoma ecosystem by single-cell transcriptomic analysis. Nat Commun. 2021;12:5291.","journal-title":"Nat Commun"},{"key":"2612_CR25","doi-asserted-by":"publisher","first-page":"6268","DOI":"10.1038\/s41467-020-20019-0","volume":"11","author":"Y Zheng","year":"2020","unstructured":"Zheng Y, Chen Z, Han Y, Han L, Zou X, Zhou B, Hu R, Hao J, Bai S, Xiao H, et al. Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment. Nat Commun. 2020;11:6268.","journal-title":"Nat Commun"},{"key":"2612_CR26","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran D, Hu Z, Butte AJ. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 2017;18:220.","journal-title":"Genome Biol"},{"key":"2612_CR27","doi-asserted-by":"publisher","first-page":"i436","DOI":"10.1093\/bioinformatics\/btz363","volume":"35","author":"G Sturm","year":"2019","unstructured":"Sturm G, Finotello F, Petitprez F, Zhang JD, Baumbach J, Fridman WH, List M, Aneichyk T. Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology. Bioinformatics. 2019;35:i436\u201345.","journal-title":"Bioinformatics"},{"key":"2612_CR28","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","volume":"37","author":"AM Newman","year":"2019","unstructured":"Newman AM, Steen CB, Liu CL, Gentles AJ, Chaudhuri AA, Scherer F, Khodadoust MS, Esfahani MS, Luca BA, Steiner D, et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol. 2019;37:773\u201382.","journal-title":"Nat Biotechnol"},{"key":"2612_CR29","doi-asserted-by":"publisher","first-page":"7335","DOI":"10.1038\/s41467-021-27599-5","volume":"12","author":"HQ Dinh","year":"2021","unstructured":"Dinh HQ, Pan F, Wang G, Huang QF, Olingy CE, Wu ZY, Wang SH, Xu X, Xu XE, He JZ, et al. Integrated single-cell transcriptome analysis reveals heterogeneity of esophageal squamous cell carcinoma microenvironment. Nat Commun. 2021;12:7335.","journal-title":"Nat Commun"},{"key":"2612_CR30","doi-asserted-by":"publisher","first-page":"3715","DOI":"10.1038\/s41467-020-17492-y","volume":"11","author":"J Yao","year":"2020","unstructured":"Yao J, Cui Q, Fan W, Ma Y, Chen Y, Liu T, Zhang X, Xi Y, Wang C, Peng L, et al. Single-cell transcriptomic analysis in a mouse model deciphers cell transition states in the multistep development of esophageal cancer. Nat Commun. 2020;11:3715.","journal-title":"Nat Commun"},{"key":"2612_CR31","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuan CH, Myung P, Plikus MV, Nie Q. Inference and analysis of cell-cell communication using Cell Chat. Nat Commun. 2021;12:1088.","journal-title":"Nat Commun"},{"key":"2612_CR32","doi-asserted-by":"publisher","DOI":"10.15252\/msb.20209923","volume":"17","author":"D Turei","year":"2021","unstructured":"Turei D, Valdeolivas A, Gul L, Palacio-Escat N, Klein M, Ivanova O, Olbei M, Gabor A, Theis F, Modos D, et al. Integrated intra- and intercellular signaling knowledge for multicellular omics analysis. Mol Syst Biol. 2021;17: e9923.","journal-title":"Mol Syst Biol"},{"key":"2612_CR33","first-page":"1125","volume":"2","author":"MT Chow","year":"2014","unstructured":"Chow MT, Luster AD. Chemokines in cancer. Cancer. Immunol Res. 2014;2:1125\u201331.","journal-title":"Immunol Res"},{"key":"2612_CR34","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nri.2017.49","volume":"17","author":"N Nagarsheth","year":"2017","unstructured":"Nagarsheth N, Wicha MS, Zou W. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nat Rev Immunol. 2017;17:559\u201372.","journal-title":"Nat Rev Immunol"},{"key":"2612_CR35","doi-asserted-by":"publisher","first-page":"5337","DOI":"10.1038\/onc.2016.34","volume":"35","author":"EW Lin","year":"2016","unstructured":"Lin EW, Karakasheva TA, Hicks PD, Bass AJ, Rustgi AK. The tumor microenvironment in esophageal cancer. Oncogene. 2016;35:5337\u201349.","journal-title":"Oncogene"},{"key":"2612_CR36","doi-asserted-by":"publisher","first-page":"7866","DOI":"10.1038\/ncomms8866","volume":"6","author":"JA Ramilowski","year":"2015","unstructured":"Ramilowski JA, Goldberg T, Harshbarger J, Kloppmann E, Lizio M, Satagopam VP, Itoh M, Kawaji H, Carninci P, Rost B, Forrest ARR. A draft network of ligand\u2013receptor-mediated multicellular signalling in human. Nat Commun. 2015;6:7866.","journal-title":"Nat Commun"},{"key":"2612_CR37","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1186\/s12885-020-07073-z","volume":"20","author":"X Jiang","year":"2020","unstructured":"Jiang X, Huang Z, Sun X, Zheng X, Liu J, Shen J, Jia B, Luo H, Mai Z, Chen G, Zhao J. CCL18-NIR1 promotes oral cancer cell growth and metastasis by activating the JAK2\/STAT3 signaling pathway. BMC Cancer. 2020;20:632.","journal-title":"BMC Cancer"},{"key":"2612_CR38","doi-asserted-by":"crossref","unstructured":"Zeng D, Li M, Zhou R, Zhang J, Sun H, Shi M, Bin J, Liao Y, Rao J, Liao W: Tumor microenvironment characterization in gastric cancer identifies prognostic and immunotherapeutically relevant gene signatures. Cancer Immunol Res 2019:canimm.0436.2018.","DOI":"10.1158\/2326-6066.CIR-18-0436"},{"key":"2612_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.879326","volume":"12","author":"Z Sui","year":"2022","unstructured":"Sui Z, Wu X, Du L, Wang H, Yuan L, Zhang JV, Yu Z. Characterization of the immune cell infiltration landscape in esophageal squamous cell carcinoma. Front Oncol. 2022;12: 879326.","journal-title":"Front Oncol"},{"key":"2612_CR40","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1373234","volume":"7","author":"C-L Chen","year":"2018","unstructured":"Chen C-L, Wang Y, Huang C-Y, Zhou Z-Q, Zhao J-J, Zhang X-F, Pan Q-Z, Wu J-X, Weng D-S, Tang Y, et al. IL-17 induces antitumor immunity by promoting beneficial neutrophil recruitment and activation in esophageal squamous cell carcinoma. OncoImmunology. 2018;7: e1373234.","journal-title":"OncoImmunology"},{"key":"2612_CR41","first-page":"2031","volume":"6","author":"T Xia","year":"2016","unstructured":"Xia T, Tong S, Fan K, Zhai W, Fang B, Wang SH, Wang JJ. XBP1 induces MMP-9 expression to promote proliferation and invasion in human esophageal squamous cell carcinoma. Am J Cancer Res. 2016;6:2031\u201340.","journal-title":"Am J Cancer Res"},{"key":"2612_CR42","doi-asserted-by":"crossref","unstructured":"Huang R, Li S, Tian C, Zhou P, Zhao H, Xie W, Xiao J, Wang L, Habimana JdD, Lin Z, et al: Thermal stress involved in TRPV2 promotes tumorigenesis through the pathways of HSP70\/27 and PI3K\/Akt\/mTOR in esophageal squamous cell carcinoma. British Journal of Cancer 2022.","DOI":"10.1038\/s41416-022-01896-2"},{"key":"2612_CR43","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.15252\/embr.201439246","volume":"15","author":"MW Pickup","year":"2014","unstructured":"Pickup MW, Mouw JK, Weaver VM. The extracellular matrix modulates the hallmarks of cancer. EMBO Rep. 2014;15:1243\u201353.","journal-title":"EMBO Rep"},{"key":"2612_CR44","doi-asserted-by":"publisher","first-page":"4895","DOI":"10.1158\/1078-0432.CCR-03-0760","volume":"10","author":"JE De Larco","year":"2004","unstructured":"De Larco JE, Wuertz BRK, Furcht LT. The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8. Clin Cancer Res. 2004;10:4895\u2013900.","journal-title":"Clin Cancer Res"},{"key":"2612_CR45","doi-asserted-by":"publisher","first-page":"6795","DOI":"10.1158\/0008-5472.CAN-17-2285","volume":"77","author":"GC Prendergast","year":"2017","unstructured":"Prendergast GC, Malachowski WP, DuHadaway JB, Muller AJ. Discovery of IDO1 inhibitors: from bench to bedside. Cancer Res. 2017;77:6795\u2013811.","journal-title":"Cancer Res"},{"key":"2612_CR46","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.immuni.2013.07.008","volume":"39","author":"J Galon","year":"2013","unstructured":"Galon J, Angell HK, Bedognetti D, Marincola FM. The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures. Immunity. 2013;39:11\u201326.","journal-title":"Immunity"},{"key":"2612_CR47","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/nrc3971","volume":"15","author":"DP Tabassum","year":"2015","unstructured":"Tabassum DP, Polyak K. Tumorigenesis: it takes a village. Nat Rev Cancer. 2015;15:473\u201383.","journal-title":"Nat Rev Cancer"},{"key":"2612_CR48","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/onc.2017.387","volume":"37","author":"Y Qiao","year":"2018","unstructured":"Qiao Y, Zhang C, Li A, Wang D, Luo Z, Ping Y, Zhou B, Liu S, Li H, Yue D, et al. IL6 derived from cancer-associated fibroblasts promotes chemoresistance via CXCR7 in esophageal squamous cell carcinoma. Oncogene. 2018;37:873\u201383.","journal-title":"Oncogene"},{"key":"2612_CR49","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00262-016-1931-5","volume":"66","author":"Y Zhu","year":"2017","unstructured":"Zhu Y, Li M, Bo C, Liu X, Zhang J, Li Z, Zhao F, Kong L, Yu J. Prognostic significance of the lymphocyte-to-monocyte ratio and the tumor-infiltrating lymphocyte to tumor-associated macrophage ratio in patients with stage T3N0M0 esophageal squamous cell carcinoma. Cancer Immunol Immunother. 2017;66:343\u201354.","journal-title":"Cancer Immunol Immunother"},{"key":"2612_CR50","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/42716","volume":"387","author":"GJ Adema","year":"1997","unstructured":"Adema GJ, Hartgers F, Verstraten R, de Vries E, Marland G, Menon S, Foster J, Xu Y, Nooyen P, McClanahan T, et al. A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature. 1997;387:713\u20137.","journal-title":"Nature"},{"key":"2612_CR51","doi-asserted-by":"publisher","first-page":"128","DOI":"10.4049\/jimmunol.1003616","volume":"189","author":"C Chenivesse","year":"2012","unstructured":"Chenivesse C, Chang Y, Azzaoui I, Ait Yahia S, Morales O, Ple C, Foussat A, Tonnel AB, Delhem N, Yssel H, et al. Pulmonary CCL18 recruits human regulatory T cells. J Immunol. 2012;189:128\u201337.","journal-title":"J Immunol"},{"key":"2612_CR52","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","volume":"41","author":"J Murray Peter","year":"2014","unstructured":"Murray Peter J, Allen Judith E, Biswas Subhra K, Fisher Edward A, Gilroy Derek W, Goerdt S, Gordon S, Hamilton John A, Ivashkiv Lionel B, Lawrence T, et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity. 2014;41:14\u201320.","journal-title":"Immunity"},{"key":"2612_CR53","first-page":"376","volume":"4","author":"JG Quatromoni","year":"2012","unstructured":"Quatromoni JG, Eruslanov E. Tumor-associated macrophages: function, phenotype, and link to prognosis in human lung cancer. Am J Transl Res. 2012;4:376\u201389.","journal-title":"Am J Transl Res"},{"key":"2612_CR54","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1053\/j.gastro.2004.05.031","volume":"127","author":"SY Leung","year":"2004","unstructured":"Leung SY, Yuen ST, Chu KM, Mathy JA, Li R, Chan AS, Law S, Wong J, Chen X, So S. Expression profiling identifies chemokine (C-C motif) ligand 18 as an independent prognostic indicator in gastric cancer. Gastroenterology. 2004;127:457\u201369.","journal-title":"Gastroenterology"},{"key":"2612_CR55","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1128\/MCB.19.3.2278","volume":"19","author":"S Lev","year":"1999","unstructured":"Lev S, Hernandez J, Martinez R, Chen A, Plowman G, Schlessinger J. Identification of a novel family of targets of PYK2 related to Drosophila retinal degeneration B (rdgB) protein. Mol Cell Biol. 1999;19:2278\u201388.","journal-title":"Mol Cell Biol"},{"key":"2612_CR56","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41419-018-0486-0","volume":"9","author":"H Ye","year":"2018","unstructured":"Ye H, Zhou Q, Zheng S, Li G, Lin Q, Wei L, Fu Z, Zhang B, Liu Y, Li Z, Chen R. Tumor-associated macrophages promote progression and the Warburg effect via CCL18\/NF-kB\/VCAM-1 pathway in pancreatic ductal adenocarcinoma. Cell Death Dis. 2018;9:453.","journal-title":"Cell Death Dis"},{"key":"2612_CR57","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1365-2567.2011.03541.x","volume":"135","author":"IU Schraufstatter","year":"2012","unstructured":"Schraufstatter IU, Zhao M, Khaldoyanidi SK, Discipio RG. The chemokine CCL18 causes maturation of cultured monocytes to macrophages in the M2 spectrum. Immunology. 2012;135:287\u201398.","journal-title":"Immunology"},{"key":"2612_CR58","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature22396","volume":"545","author":"SR Gordon","year":"2017","unstructured":"Gordon SR, Maute RL, Dulken BW, Hutter G, George BM, McCracken MN, Gupta R, Tsai JM, Sinha R, Corey D, et al. PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity. Nature. 2017;545:495.","journal-title":"Nature"},{"key":"2612_CR59","doi-asserted-by":"publisher","first-page":"4353","DOI":"10.1038\/s41467-019-12384-2","volume":"10","author":"T Yu","year":"2019","unstructured":"Yu T, Gan S, Zhu Q, Dai D, Li N, Wang H, Chen X, Hou D, Wang Y, Pan Q, et al. Modulation of M2 macrophage polarization by the crosstalk between Stat6 and Trim24. Nat Commun. 2019;10:4353.","journal-title":"Nat Commun"},{"key":"2612_CR60","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1016\/j.apsb.2021.03.009","volume":"11","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Sun J, Li Y, Zhou X, Zhai W, Wu Y, Chen G, Gou S, Sui X, Zhao W, et al. Tryptophan 2,3-dioxygenase 2 controls M2 macrophages polarization to promote esophageal squamous cell carcinoma progression via AKT\/GSK3\u03b2\/IL-8 signaling pathway. Acta Pharm Sin B. 2021;11:2835\u201349.","journal-title":"Acta Pharm Sin B"},{"key":"2612_CR61","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/ni.3306","volume":"17","author":"CK Glass","year":"2016","unstructured":"Glass CK, Natoli G. Molecular control of activation and priming in macrophages. Nat Immunol. 2016;17:26\u201333.","journal-title":"Nat Immunol"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-023-02612-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-023-02612-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-023-02612-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T07:05:10Z","timestamp":1677481510000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-023-02612-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,27]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2612"],"URL":"https:\/\/doi.org\/10.1186\/s13046-023-02612-5","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,27]]},"assertion":[{"value":"7 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patient samples in this study were collected with informed consent for research use and approved by the institutional research ethics committee of the Affiliated Cancer Hospital of Zhengzhou University \/ Henan Cancer Hospital (protocol numbers 2017407) in accordance with the Declaration of Helsinki. Animal experiments in this study were approved by the Ethics Committee of the Zhengzhou University (ethical approval code number: ZZUIRB2021-32).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}